Press release
Trientine Hydrochloride Market is Expected To Reach US$ 0.75 Bn by 2023: Credence Research
New Market Research Reports Title “Trientine Hydrochloride Market - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023” Has Been Added to Credenceresearch.com Report Database.CR Logo
According to a new market report published by Credence Research “Trientine Hydrochloride Market - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023,” the trientine hydrochloride market was valued at US$ 0.42 Bn in 2015, and is expected to reach US$ 0.75 Bn by 2023, expanding at a CAGR of 7.5% from 2016 to 2023.
Browse the full Trientine Hydrochloride Market for Epoxy Curing and Wilson’s Disease Application - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 – 2023 report at http://www.credenceresearch.com/report/trientine-hydrochloride-market
Market Insights
Trientine hydrochloride is anticipated to experience high demand from the pharmaceutical industry in the global market. The functions of trientine hydrochloride have led to high demand from the global market. Trientine hydrochloride also known as trientine dihydrochloride is a white to pale yellow crystalline hygroscopic powder which is soluble in methanol, water but insoluble in ether and chloroform. It is known in the industry for its use as a chelating compound in removal of excess copper which accumulates in the human body. Hence, growing demand is expected for trientine from major pharmaceutical industries worldwide.
The global trientine hydrochloride market is segmented into epoxy curing and Wilson’s disease. Among these, Wilson’s disease accounted for larger share of global trientine hydrochloride market. Wilson’s disease is a rare autosomal recessive inherited disorder of copper metabolism which is characterized by excessive deposition of copper in the brain, liver and other tissues in the body. Wilson’s disease is often fatal if not treated when indicative. Growing number of pharmaceutical industries and rising awareness regarding health and personal care are the major factors responsible for the growth of global trientine hydrochloride market. Therefore, pharmaceutical and healthcare sector are the major consumers of trientine hydrochloride, thereby leading to high demand for trientine during the forecast period.
Competitive Insights:
Many people around the globe are suffering from wide variety of diseases. Some are suffering from genetic diseases and some from acquired diseases. Among the genetic diseases is Wilson’s disease. Many people in the world are suffering from this genetic disease which is a rare autosomal recessive inherited disorder of copper metabolism. This leads to excessive deposition of copper in the brain, liver and other tissues in the body. Anything in excess can be fatal to the human body. Therefore, removal of excess copper is necessary to prevent fatal incidents. Trientine hydrochloride is the cure for Wilson’s disease. It is used to remove excess copper present in the human body. Hence, high demand is reported for trientine hydrochloride from the healthcare industries worldwide.
Asia Pacific accounted for more than 47.0% share of global trientine hydrochloride market in 2015 and is expected to retain its position during the forecast period. Growing demand from the pharmaceutical industry is the major factor boosting high demand for trientine hydrochloride in the global market. Therefore, Asia Pacific is expected to promote high growth for trientine hydrochloride in the near future. Europe accounted as the second largest market for trientine hydrochloride. Other regions such as North America, Latin America and Middle East and Africa are also expected to boost high demand for trientine hydrochloride during the forecast period from 2016 to 2023.
Key Trends:
Manufacture of various medicines
Treatment for Wilson’s disease
Opportunities from increasing research activities for increase in application scope of trientine hydrochloride in the pharmaceutical industry
Browse the full Trientine Hydrochloride Market for Epoxy Curing and Wilson’s Disease Application - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 – 2023 report at http://www.credenceresearch.com/report/trientine-hydrochloride-market
Company: http://www.credenceresearch.com
Request Sample: http://www.credenceresearch.com/sample-request/58081
Blog: http://www.globalpharmaindustry.com/
Media Contact
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: sales@credenceresearch.com
Phone: +1-800-361-8290
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
State: California
Country: United States
Website: http://www.credenceresearch.com/report/trientine-hydrochloride-market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: sales@credenceresearch.com
Phone: +1-800-361-8290
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
State: California
Country: United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Trientine Hydrochloride Market is Expected To Reach US$ 0.75 Bn by 2023: Credence Research here
News-ID: 519045 • Views: …
More Releases from Credence Research Inc
Trauma Products Market Projected to Hit USD 14806.4 Million by 2032, Expanding a …
Market Overview
The Trauma Products Market size was valued at USD 9575 million in 2024 and is anticipated to reach USD 14806.4 million by 2032, at a CAGR of 5.6% during the forecast period.
Strong demand for trauma products stems from rising accident rates and increased surgical procedures across hospitals worldwide. Growing elderly populations prone to fractures boost need for fixation devices and implants. Healthcare providers upgrade trauma care infrastructure to handle…
Laminated Can Packaging Market Projected to Hit USD 15463 Million by 2032, Expan …
Market Outlook
The Laminated Can Packaging market reached USD 10,230 million in 2024 and is expected to grow to USD 15,463 million by 2032, posting a CAGR of 5.3% during the forecast period. Demand rises due to strong use in food, beverage, and personal care products. Brands adopt laminated cans to gain better shelf appeal and longer product safety. Growth also comes from rising interest in lightweight and corrosion-resistant formats. Manufacturers…
Americas-blood-glucose-test-strip-packaging-market to Reach USD 341.2 million by …
Market Overview:
The Americas-blood-glucose-test-strip-packaging-market continues to expand due to rising diabetes screening and stronger adoption of home-based testing solutions. The Americas-blood-glucose-test-strip-packaging-market size was valued at USD 231 million in 2024 and is anticipated to reach USD 341.2 million by 2032, at a CAGR of 5% during the forecast period.
The Americas-blood-glucose-test-strip-packaging-market grows due to stronger use of self-monitoring tools among diabetic patients and wider access to fast diagnostic kits. Producers develop…
Global Coated Recycled Paperboard Market Projected to Hit USD 14,458.7 Million b …
Market Overview
The Global Coated Recycled Paperboard Market size was valued at USD 10,001.4 million in 2024 and is anticipated to reach USD 14,458.7 million by 2032, at a CAGR of 4.70% during the forecast period.
Growing adoption across FMCG, food and beverage, household goods, and personal care drives higher market engagement. Companies select coated recycled paperboard to balance cost efficiency with stronger sustainability commitments. It supports better packaging visibility…
More Releases for Trientine
Wilson Disease Market is expected to reach USD 4.6 billion by 2034
Wilson Disease is a rare autosomal recessive genetic disorder caused by mutations in the ATP7B gene, leading to impaired copper metabolism. Excessive copper accumulation in the liver, brain, and other organs results in hepatic, neurological, and psychiatric manifestations. The estimated global prevalence is about 1 in 30,000 individuals, though diagnosis often remains delayed due to variable symptoms.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71677
Historically, treatment has relied on…
Wilson's Disease Drugs Market Insights 2025-2034: Growth Forecast and Strategic …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Wilson's Disease Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for drugs treating Wilson's disease has seen robust growth of late. An upward trajectory is expected with growth from $0.62 billion in 2024 to $0.66 billion in 2025, reflecting a compound annual…
Wilson's Disease Market Expected to rise, 2034 | Orphalan, AstraZeneca,Vivet The …
The Wilson's Disease market growth is driven by factors like increase in the prevalence of Wilson's Disease, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Wilson's Disease market report [https://www.delveinsight.com/report-store/wilson-disease-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Wilson's Disease market size, share, Wilson's Disease epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and…
Wilson Disease Market Size in the 7MM was ~USD 290 Million in 2022, estimated De …
DelveInsight's 'Wilson's Disease Market Insights, Epidemiology, and Market Forecast - 2034' report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of Wilson Disease in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
Explore the intricate details of the Wilson Disease Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Wilson Disease Market Forecast. Click here…
Wilson Disease Drugs Market Trends, Size, Share and Forecast 2022-2028
The global Wilson disease drugs market is expected to grow at a CAGR of 4.5% during the forecast period (2022-2028). Various strategies adopted by the key players and FDA-approved drugs for the treatment of Wilson's disease are supporting the growth of the global Wilson disease drugs market. For instance, in May 2022, the US FDA approved Cuvrior for the treatment of stable Wilson diseases in adults, who are decoppered and…
Wilson Disease Pipeline Analysis: 5+ Companies are Working to Improve the Treatm …
DelveInsight's, "Wilson Disease Pipeline Insight, 2022," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Wilson Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from Wilson Disease Pipeline Report
• DelveInsight's Wilson Disease Pipeline…
